Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis. [PDF]
Dis Markers, 2018 Ha YJ +6 more
europepmc +1 more source
Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents. [PDF]
Cancer Res, 2019 Zuazo-Gaztelu I +10 more
europepmc +1 more source
Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway. [PDF]
Tumori, 2019 Lu JJ, Su YW, Wang CJ, Li DF, Zhou L.
europepmc +1 more source
Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure? [PDF]
ESC Heart Fail, 2018 Willner N +3 more
europepmc +1 more source
Semaphorin 4D promotes inhibitory synapse formation and suppresses seizures in vivo. [PDF]
Epilepsia, 2018 Acker DWM, Wong I, Kang M, Paradis S.
europepmc +1 more source
Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma. [PDF]
Blood Cancer J, 2018 Terpos E +9 more
europepmc +1 more source
Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma. [PDF]
Int J Oncol, 2017 Takada H +14 more
europepmc +1 more source
Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis. [PDF]
Ann Rheum Dis, 2017 Nishide M +20 more
europepmc +1 more source
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trial. [PDF]
Neurol Neuroimmunol Neuroinflamm, 2017 LaGanke C +13 more
europepmc +1 more source